Company news
Ocumension Therapeutics news in 2020
Ocumension Therapeutics's news releases, calls and decks from 2020, newest first.
Voluntary announcement phase iii clinical trial of OT-1001 (zerviate) approved in china
September 21, 2020
Announcement acquisition of 100% equity interest in suzhou xiaxiang and change in use of proceeds from the listing
September 11, 2020
Interim results announcement for the six months ended June 30, 2020
August 26, 2020